Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate

Bone. 2019 Mar:120:101-113. doi: 10.1016/j.bone.2018.10.014. Epub 2018 Oct 16.

Abstract

This study evaluated the effects of antimicrobial photodynamic therapy (aPDT) in the alveolar repair of rats with major risk factors for bisphosphonate-related osteonecrosis of the jaws (BRONJ). Senile rats received 0.45 ml of vehicle (VEH and VEH/aPDT) or 0.45 ml of zoledronate (ZOL and ZOL/aPDT) every three days for seven weeks. After three weeks of treatment, the first lower left molar was extracted. VEH/aPDT and ZOL/aPDT were submitted to aPDT on the extraction site at 0, 2 and 4 days postoperatively. Euthanasia was performed 28 days postoperatively and the extraction site was evaluated by clinical, histological, histometric, histochemical and immunohistochemical analysis. ZOL showed tissue repair impairment; lower percentage of newly formed bone tissue (NFBT); higher percentage of non-vital bone tissue (NVBT); fewer mature collagen fibers and increased immunolabeling for tumor necrosis factor (TNFα), interleukin (IL)-1β and IL-6. ZOL/aPDT showed clinical and histological characteristics of the extraction site, percentage of NFBT and percentage of mature collagen fiber similar to VEH. Percentage of NVBT and immunolabeling for inflammatory cytokines in ZOL/aPDT was lower than in ZOL. Immunolabeling for tartarato-resistant acid phosphatase (TRAP) was lower in ZOL and ZOL/aPDT. aPDT in the dental extraction site improves tissue repair process and prevents the occurrence of BRONJ-like lesions after tooth extraction.

Keywords: Bisphosphonate-related osteonecrosis of the jaws; Photochemotherapy; Prevention; Tooth socket; Wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / pathology
  • Alveolar Process / drug effects
  • Alveolar Process / pathology*
  • Animals
  • Anti-Infective Agents / therapeutic use*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / drug therapy*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / prevention & control
  • Collagen / metabolism
  • Female
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Mouth Mucosa / pathology
  • Osteogenesis
  • Photochemotherapy*
  • Rats, Wistar
  • Tartrate-Resistant Acid Phosphatase / metabolism
  • Tooth Extraction / adverse effects*
  • Tumor Necrosis Factor-alpha / metabolism
  • Wound Healing / drug effects
  • Zoledronic Acid / adverse effects*

Substances

  • Anti-Infective Agents
  • Interleukin-1beta
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Zoledronic Acid
  • Collagen
  • Tartrate-Resistant Acid Phosphatase